Ledger.Open graph →
SEC Form D · Amendment · filed March 8, 2012

VentiRx Pharmaceuticals Inc

Offering
$25.0M
Sold
$18.8M
Exemption
—
Industry
Biotechnology
Location
Seattle, WA
Type
—

People & firms on this filing (11)

Kent M. Snyder · Seattle, WADirectorPatrick M. Heron · Seattle, WADirectorSteven M. Gillis, Ph.D · Mercer Island, WADirectorNicole M. Vitullo · Princeton, NJDirectorChristopher J. Velis · Littleton, MADirectorJohn Cunningham · BELLEVUE, WADirectorYogen Dalal · BELLEVUE, WADirectorTimothy M. Brown · Boston, MADirectorRobert M. Hershberg, M.D., Ph.D · Seattle, WAExec · DirectorAtul M. Saran · Gaithersburg, MDDirectorElliot M. Grossbard, M.D · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗